GERM vs. IDVO
GERM (Amplify Treatments, Testing and Advancements ETF) and IDVO (Amplify CWP International Enhanced Dividend Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while IDVO is a Derivative Income fund actively managed by Amplify. GERM is passively managed, while IDVO is actively managed. Over the past year, GERM returned 0.00% vs 35.28% for IDVO. GERM charges 0.68%/yr vs 0.65%/yr for IDVO.
Performance
GERM vs. IDVO - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDVO
- 1D
- -1.25%
- 1M
- 2.08%
- YTD
- 14.12%
- 6M
- 14.66%
- 1Y
- 35.28%
- 3Y*
- 23.82%
- 5Y*
- —
- 10Y*
- —
GERM vs. IDVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
IDVO Amplify CWP International Enhanced Dividend Income ETF | 14.12% | 36.46% | 2.80% |
GERM vs. IDVO - Sectors Allocation Comparison
Sectors
GERM
IDVO
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
GERM
IDVO
Financial Services
GERM
IDVO
Basic Materials
GERM
-
IDVO
Communication Services
GERM
-
IDVO
Consumer Cyclical
GERM
-
IDVO
Consumer Defensive
GERM
-
IDVO
Energy
GERM
-
IDVO
Industrials
GERM
-
IDVO
Real Estate
GERM
-
IDVO
-
Technology
GERM
-
IDVO
Utilities
GERM
-
IDVO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. IDVO — Risk / Return Rank
GERM
IDVO
GERM vs. IDVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify CWP International Enhanced Dividend Income ETF (IDVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| GERM | IDVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.27 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 1.38 | — |
Drawdowns
GERM vs. IDVO - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum IDVO drawdown of -15.46%. Use the drawdown chart below to compare losses from any high point for GERM and IDVO.
Loading charts...
Drawdown Indicators
| GERM | IDVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -15.46% | +15.46% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -10.37% | +10.37% |
Max Drawdown (3Y)Largest decline over 3 years | — | -15.46% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.25% | +1.25% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -2.30% | +2.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 2.67% | -2.67% |
Volatility
GERM vs. IDVO - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify CWP International Enhanced Dividend Income ETF (IDVO) has a volatility of 5.20%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than IDVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | IDVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 5.20% | -5.20% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 13.05% | -13.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 15.61% | -15.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 16.36% | -16.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 16.36% | -16.36% |
GERM vs. IDVO - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than IDVO's 0.65% expense ratio.
Dividends
GERM vs. IDVO - Dividend Comparison
GERM has not paid dividends to shareholders, while IDVO's dividend yield for the trailing twelve months is around 5.48%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IDVO Amplify CWP International Enhanced Dividend Income ETF | 5.48% | 5.42% | 6.14% | 5.72% | 1.96% |
Frequently Asked Questions
IDVO has higher volatility (5.20%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs IDVO's -15.46%.
On 1-year performance, IDVO leads with 35.28% vs 0.00% for GERM. On fees, IDVO is cheaper at 0.65% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IDVO has performed better with a 35.28% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDVO is cheaper with a 0.65% expense ratio, compared with 0.68% for GERM.
IDVO has the higher dividend yield at 5.48%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while IDVO is Derivative Income. Their fees differ too: 0.68% for GERM and 0.65% for IDVO.
Find the right allocation for GERM and IDVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer